ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.317,10
0,00%
S&P 500
5.918,25
0,00%
Dow Jones
42.635,20
0,00%
Euro vs US Dollar
1,02946
-0,19%
Bitcoin
92.927,99
-2,24%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Milestone Pharmaceuticals Inc (MIST)

  7. Milestone Pharmaceuticals Inc (MIST) News

MIST

Milestone Pharmaceuticals (MIST)

Milestone Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MIST
DatumZeitQuelleÜberschriftSymbolFirma
07/01/202514h00GlobeNewswire Inc.Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MISTMilestone Pharmaceuticals Inc
25/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MISTMilestone Pharmaceuticals Inc
12/11/202422h38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MISTMilestone Pharmaceuticals Inc
12/11/202422h36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MISTMilestone Pharmaceuticals Inc
12/11/202415h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
12/11/202413h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
04/09/202414h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
29/08/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
29/08/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
29/08/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
29/08/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
29/08/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
29/08/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
08/08/202422h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
08/08/202422h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
17/07/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
17/07/202422h16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
17/07/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
17/07/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MISTMilestone Pharmaceuticals Inc
17/07/202400h06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:MISTMilestone Pharmaceuticals Inc
15/07/202422h41Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MISTMilestone Pharmaceuticals Inc
15/07/202422h38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MISTMilestone Pharmaceuticals Inc
15/07/202422h36Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MISTMilestone Pharmaceuticals Inc
15/07/202422h34Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MISTMilestone Pharmaceuticals Inc
15/07/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
29/05/202413h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
22/05/202414h00GlobeNewswire Inc.Milestone Pharmaceuticals Partners with Arrhythmia Alliance on SVT AwarenessNASDAQ:MISTMilestone Pharmaceuticals Inc
13/05/202413h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
13/05/202412h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MISTMilestone Pharmaceuticals Inc
04/03/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MISTMilestone Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MIST

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
CCOM
US500
US 500
NASDAQ
NVDA
NVIDIA
FX
EURUSD
Euro vs US Dollar
COIN
ADAUSD
Cardano
NYSE
KO
Coca Cola
CCOM
SILVER
SILVER
CCOM
US100
US Tech 100
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
TG
NOV
Novo Nordisk
TG
CBK
Commerzbank
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten